{"id":181659,"name":"C-PATH INSTITUTE","slug":"c-path-institute","state":"AZ","country":"United States of America","description":"","totalSpending":480000,"filings":32,"yearlySpending":[{"year":2018,"income":60000},{"year":2019,"income":60000},{"year":2020,"income":60000},{"year":2021,"income":60000},{"year":2022,"income":60000},{"year":2023,"income":60000},{"year":2024,"income":60000},{"year":2025,"income":60000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["AMERICAN CAPITOL GROUP"],"lobbyists":["DAVE LARSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Reauthorization of the Critical Path Public Private Partnership Program at FDA","Funding for the Critical Path Public Private Partnerships at FDA","Reauthorization of the Critical Path Public Private Partnership Program at FDA","Funding for the Critical Path Public Private Partnerships at FDA","Funding for the Critical Path Public Private Partnerships at FDA"]}